Attovia Therapeutics to Present New Data on ATTO-1310 and ATTO-2306 at EADV 2026 and Fall Clinical Dermatology Conference 2026

ConferenceATTO-1310ATTO-2306Positive

AI Analysis

Summary

Attovia Therapeutics announced it will present clinical, translational, and preclinical data on ATTO-1310 and ATTO-2306 at the EADV Congress 2026 and Fall Clinical Dermatology Conference 2026.

Importance:4/10

Sentiment:

0.30

pipelineclinical-stagedermatologyimmune-mediated diseasesconference presentation

Related Companies

$ATTO

Read the original article

Published by GlobeNewswire Clinical Studies on September 28, 2026 8:05 PM

Read Original